Sofinnova Partners exceeds target with €165m biotech acceleration fund close, Europe’s largest, with strong Pharma support Sofinnova Partners announced the final close of Sofinnova Biovelocita II. The fund has exceeded its target, successfully raising €165M, with substantial backing from the top global pharmaceutical companies, including Amgen, Bristol Myers Squibb, and Pfizer Ventures. iOnctura strengthens leadership […]
Like other industries, Biotech and Pharma are viewing the Trump administration with some trepidation. One concern – among many – is whether job cuts instituted by the US’s Department of Government Efficiency (DOGE), led by Elon Musk, will slow down the rate of drug approvals. Among the agencies hit are the Food and Drugs Administration […]
SpliceBio announces first patient dosed in Phase 1/2 ASTRA study of SB-007, a dual-AAV gene therapy for Stargardt disease SpliceBio, a clinical-stage genetic medicines company pioneering Protein Splicing to address diseases caused by mutations in large genes, announced that it has dosed the first patient in its Phase 1/2 ASTRA study of SB-007. SpliceBio’s dual […]
On Thursday UK Prime Minister Sir Keir Starmer abolished NHS England, the organisation that’s been responsible for running the health service’s day-to-day operations for the last 13 years. This was unexpected, and a radical move. Nobody in Westminster, or the NHS, saw it coming. Why did he do it? Who will run the NHS in […]
‘Fail to prepare, prepare to fail’ – an old adage that couldn’t be truer when it comes to maximising your valuable time and resources when attending conferences. Ahead of spring conference season, here are Optimum’s top tips on how you can ensure you’re (a) attending the right events and (b) utilising the opportunities you hope […]
